A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy.
Abstract
Data di Pubblicazione:
2011
Citazione:
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy / Guaraldi, Giovanni; Zona, Stefano; Cossarizza, Andrea; L., Vernacotola; Carli, Federica; A., Lattanzi; Beghetto, Barbara; Orlando, Gabriella; R., Termini; M., Garau. - In: ANTIVIRAL THERAPY. - ISSN 1359-6535. - STAMPA. - 16:(2011), pp. A43-A44. ( 13th international workshop on Adverse Drug Reactions and Co-morbidities in HIV. Rome 14-16 Jul 2011).
Abstract:
MONET and MONOI have shown a small rise in cholesterol after stopping tenofovir in darunavir/ritonavir arm, without providing any information regarding endothelial function. We performed a study to compare the change in brachial artery flow mediated vasodilatation in patients receiving darunavir/ritonavir monotherapy versus triple therapy.
Tipologia CRIS:
Abstract in Rivista
Keywords:
HIV; endothelial function; darunavir
Elenco autori:
Guaraldi, Giovanni; Zona, Stefano; Cossarizza, Andrea; L., Vernacotola; Carli, Federica; A., Lattanzi; Beghetto, Barbara; Orlando, Gabriella; R., Termini; M., Garau
Link alla scheda completa:
Titolo del libro:
Abstracts
Pubblicato in: